{
  "id": "3abad61ae35b92f3",
  "title": "Phase 3 Trial Shows Teva AJOVY Effective In Children And Adolescents With Episodic Migraine",
  "description": "20260115T023000Z",
  "content": "",
  "source": "finanznachrichten.de",
  "source_url": "https://www.finanznachrichten.de/nachrichten-2026-01/67438323-phase-3-trial-shows-teva-s-ajovy-effective-in-children-and-adolescents-with-episodic-migraine-020.htm",
  "published_at": "20260115T023000Z",
  "fetched_at": "2026-01-16T00:24:08.160649+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "ai"
  ],
  "location": "Germany",
  "raw_data": {
    "url": "https://www.finanznachrichten.de/nachrichten-2026-01/67438323-phase-3-trial-shows-teva-s-ajovy-effective-in-children-and-adolescents-with-episodic-migraine-020.htm",
    "url_mobile": "",
    "title": "Phase 3 Trial Shows Teva AJOVY Effective In Children And Adolescents With Episodic Migraine",
    "seendate": "20260115T023000Z",
    "socialimage": "https://www.finanznachrichten.de/chart-teva-pharmaceutical-industries-ltd-aktie-intraklein-tradegate.png",
    "domain": "finanznachrichten.de",
    "language": "English",
    "sourcecountry": "Germany"
  }
}